Holdings of ANDERA PARTNERS
5 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 100 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 71.3 %
- FR 15.4 %
- BE 13.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 2 | 86.7M $ | 71.29 % |
| 2 | FR | 2 | 18.8M $ | 15.44 % |
| 3 | BE | 1 | 16.1M $ | 13.27 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Evommune Inc | 1,897,362 | 43.6M $ | |
| 2 | Mineralys Therapeutics Inc | 1,591,917 | 43.1M $ | |
| 3 | AGOMAB THERAPEUTICS SA | 1,538,702 | 16.1M $ | |
| 4 | Inventiva SACA | 1,818,181 | 10.1M $ | |
| 5 | Abivax SA | 78,125 | 8.7M $ |